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The effect of mutations of Newcastle disease virus (NDV) fusion (F) gene, hemagglutinin–neuraminidase (HN) gene, and phosphoprotein (P)
gene and HN chimeras between the virulent Beaudette C and low virulence LaSota strains on pathogenesis and pathogenicity was examined in
fully susceptible chickens. A virulent F cleavage site motif within a LaSota backbone increased pathogenicity and severity of clinical disease. A
LaSota HN within a Beaudette C backbone decreased pathogenicity indices and disease severity. A Beaudette C HN within a LaSota backbone did
not change either pathogenicity indices or severity of disease in chickens. Loss of glycosylation at site 4 of the HN or modified P gene of
Beaudette C decreased pathogenicity indices and caused no overt clinicopathologic disease in chickens. Both pathogenicity indices and
clinicopathologic examination demonstrated that the F, HN, and P genes of NDV collectively or individually can contribute to viral virulence.
© 2006 Elsevier Inc. All rights reserved.Keywords: Fusion protein; Hemagglutinin–neuraminidase protein; Immunohistochemistry; In situ hybridization; Phosphoprotein; Reverse genetics; Avian
paramyxovirus; Veterinary virology; Emerging diseaseIntroduction
Newcastle disease virus (NDV) or avian paramyxovirus 1
(APMV-1) is a non-segmented, single-stranded, negative-sense
RNA virus in the family Paramyxoviridae (de Leeuw and
Peeters, 1999; Krishnamurthy and Samal, 1998; Phillips et al.,
1998). The RNA genome consists of 15,186 bases and contains
six genes encoding the six structural proteins in order from 3′ to
5′: nucleoprotein (NP)–phosphoprotein (P)–matrix (M)–fusion
(F)–hemagglutinin–neuraminidase (HN)–large protein (L)
(Chambers et al., 1986; Wilde et al., 1986). In addition,⁎ Corresponding author. Fax: +1 706 546 3161.
E-mail addresses: wakamatsun@niehs.nih.gov (N. Wakamatsu),
jking@seprl.usda.gov (D.J. King).
1 Present address: Laboratory of Experimental Pathology, National Institute of
Environmental Health Sciences, Research Triangle Park, NC 27709, USA.
0042-6822/$ - see front matter © 2006 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2006.06.013transcriptional editing of the P gene mRNA results in two non-
structural proteins, V and a potential W (Peeters et al., 2004;
Steward et al., 1993).
The disease resulting from an NDV infection of birds varies
from mild to severe with high mortality depending on virulence
of the infecting strain and host susceptibility (Alexander, 1995,
2001, 2003). Because NDV strains are of a single serotype,
virulence differentiation among those strains must be deter-
mined by standard pathotyping assays. The results of those tests
which utilize inoculation of embryonated chicken eggs and live
chickens are the basis for classifying NDVas velogenic (highly
virulent), mesogenic (moderately virulent), or lentogenic (low
virulent) (Alexander, 1998). Further division of the velogenic
pathotype into viscerotropic velogenic (VVNDV) and neuro-
tropic velogenic (NVNDV) pathotypes, those strains that cause
an acute lethal disease with frequent visceral hemorrhage or an
acute and often lethal disease with neurological and respiratory
334 N. Wakamatsu et al. / Virology 353 (2006) 333–343signs, respectively, is accomplished by intracloacal inoculation
of chickens (Alexander, 1998, 2003). Pathogenesis studies to
assess virus distribution in tissues and resultant lesions from an
NDV infection have been completed by inoculation of chickens
with a lower virus dose by a natural route in contrast to the
inoculation of a high virus dose by a systemic route in
pathotyping tests (Brown et al., 1999). Prior pathogenesis
studies demonstrated that viruses of both velogenic pathotypes
produce severe clinical disease and infect multiple tissues. Gross
and histologic lesions that are the result of those infections are
usually more extensive and severe with VVNDV than with
NVNDV (Brown et al., 1999). No overt clinical signs were
usually observed with infections from either mesogenic or
lentogenic NDV. However, mesogenic isolates do cause some
gross and histologic lesions that are considerably less extensive
than those caused by a velogenic virus infection (Brown et al.,
1999; Kommers et al., 2003). Minimal lesions, if present,
occurred in birds with lentogenic infections, affecting mostly the
respiratory tract (Hamid et al., 1990). In lentogenic NDV
infections, viral replication is detected primarily at the inocula-
tion sites (Kommers et al., 2003) but minimal replication can
also be present in cardiac myofibers (Brown et al., 1999).
The marked strain-dependent difference in tropism and
virulence observed with NDV are hypothesized to depend
upon the presence of cellular proteases required for the
activation of the viral fusion glycoprotein precursor (Alex-
ander, 2001; Gotoh et al., 1992; Nagai, 1995; Nagai and
Klenk, 1977). Recent studies utilizing viruses containing
mutations generated by reverse genetics have supported the
importance of the amino acid sequence at the F cleavage site
for NDV virulence (de Leeuw et al., 2003; Panda et al., 2004b;
Peeters et al., 1999; Römer-Oberdörfer et al., 2003) and viral
distribution in embryos (Al-Garib et al., 2003). However, some
investigators have suggested involvement of other factors (de
Leeuw et al., 2003; Panda et al., 2004b). The loss of
glycosylation sites from the HN protein altered NDV
pathogenicity (Panda et al., 2004a), and HN chimeras
generated from low virulent or virulent viruses either increased
or decreased viral pathogenicity depending on the virulence of
the virus that was the origin of the HN gene (Huang et al.,
2004). Evidence for a P gene product, the V protein,
contribution to NDV virulence was demonstrated in chickens
(Huang et al., 2003), in embryonating chicken eggs (Mebat-
sion et al., 2001; Park et al., 2003a), and during in vitro cell
culture (Huang et al., 2003; Park et al, 2003a, 2003b). These
prior studies with infectious clones demonstrated the potential
role of the F, HN, and P genes in NDV virulence, but the
dissemination of these infectious clones and induction of
pathological changes was not reported for infected mature
chickens. Therefore, the purpose of this study was to extend
the understanding of the role of the F, HN, and P genes in the
pathogenesis of NDV by comparing the results of a
clinicopathologic assessment in chickens infected via a natural
route with selected wild-type NDV, their infectious clones, and
those clones with various gene changes or mutations. The
virulence of those viruses was also determined by standard
pathogenicity assays (Alexander, 1998).Results
Pathogenicity index tests
The wild-type viruses and their infectious clones utilized
for this study are depicted in Fig. 1, and a summary of the
pathogenicity test results is presented in Table 1. The indices
for recombinant Beaudette C (rBC) and recombinant LaSota
(rLaSo) were very similar to the wild-type viruses, wild-type
Beaudette C (wtBC) and wild-type LaSota (wtLaSo),
respectively, for the mean death time (MDT), the intracerebral
pathogenicity index (ICPI), and the intravenous pathogenicity
(IVPI) tests. A low virulent backbone with virulent F
cleavage site (rLaSoVF) showed markedly increased patho-
genicity indices compared to its backbone virus (rLaSo), and
the pathogenicity indices were similar to that of rBC. The HN
from a low virulent virus within a virulent backbone (rBC
LaSoHN) had mildly decreased pathogenicity indices com-
pared to rBC. The HN from a virulent virus within a low
virulent backbone (rLaSo BCHN) had similar pathogenicity
indices to rLaSo. Additional F cleavage site changes within
rLaSo BCHN (rLaSoVF BCHN) markedly increased patho-
genicity compared to rLaSo BCHN and rLaSo, and the
virulence was similar to that of rLaSoVF and rBC. Deletion
of glycosylation site 4 within the HN of rBC (rBCG4)
moderately decreased pathogenicity indices compared to rBC.
Both clones with P gene mutations (rBC/V-Stop and rBC/
Edit) had decreased pathogenicity compared to their parent
virus (rBC), but their pathogenicity was higher than that of
rLaSo.
The overt clinical signs observed in chickens following
intracloacal inoculation were tremors and paralysis, typical of
a neurotropic virus infection. Those with severe paralysis
were euthanized and recorded as dead. No overt hemorrhagic
lesions were observed in the euthanized birds following
infection with this set of viruses.
Clinicopathologic assessment in chickens—clinical disease,
gross pathology, histopathology, immunohistochemistry (IHC),
in situ hybridization (ISH), virus isolation, and serology
Wild-type and their recombinant viruses
Morbidity, mortality, and viral distribution in tissues as
detected by IHC and ISH in 4-week-old chickens are
summarized in Table 2. Birds infected with wtBC exhibited
the most severe overt disease of primarily nervous signs.
Slight depression and head tremor were evident in one bird
at 3 days post-inoculation (dpi). Whereas at 4 dpi all birds
were depressed. All the infected chickens sampled after day
5 had severe nervous signs such as incoordination
accompanied by leg paralysis and were euthanized by
10 dpi. In comparison, birds inoculated with rBC had a
lower frequency of severe disease. All birds were slightly
depressed by 4 dpi. Some birds infected with rBC had
similar nervous signs to those seen in birds inoculated with
wtBC. However, the number of birds euthanized because of
severe disease was only 30%. Chickens infected with wtBC
Fig. 1. Wild-type Newcastle disease viruses and their infectious clones.
335N. Wakamatsu et al. / Virology 353 (2006) 333–343or rBC had severe histologic lesions including encephalitis,
lymphoid depletion, airsacculitis, and pancreatic exocrine
cell necrosis. Viral proteins and mRNAs were detected
systemically, predominantly in the lymphoid tissues (Fig.
2A), respiratory tissues, heart, and brain (Fig. 2B). Viral
distribution as determined by IHC and ISH, within the
gastrointestinal tract was detected in birds with wtBC, but
not with rBC. Recombinant LaSota (rLaSo) and its parent
virus (wtLaSo) induced no overt clinical signs of disease,
and there were no histologic lesions in tissues. Viral
infection, as detected by IHC, was restricted to inoculation
sites with rLaSo and wtLaSo viruses.Fusion cleavage activation site mutations
Severe neurological clinical signs also occurred in
chickens inoculated with rLaSoVF. Nervous signs such as
leg paralysis and head twitching were first observed at 4 dpi.
Birds showing nervous signs initially were relatively bright
and had minimal depression, but the nervous signs increased
in severity with time and 60% were euthanized. Principal
histologic lesions were lymphoid depletion in all lymphoid
tissues and non-suppurative encephalitis. Virus was distrib-
uted to multiple systemic sites including lymphoid tissues,
respiratory tissues (Fig. 2C), gastrointestinal tract, pancreas
(Fig. 2D), and brain, but no virus was detected in the heart.
Table 1
Pathogenicity index results and amino acid sequence at the fusion cleavage
activation site of wild-type NDV strains and their infectious clones
Gene
changes




wtBC 50 1.75 2.29 4/2 (5) Virulent
rBC 48 1.66 2.06 2/2 (5) Virulent
wtLaSo >90 0.00 0.01 ND f Low
virulent
rLaSo >90 0.19 0.00 ND Low
virulent
F rLaSoVF 59 1.69 2.39 4/4 (5) Virulent
HN rBC
LaSoHN
60 1.58 1.27 0/0 (5) Virulent
rBCG4 77 1.31 0.56 0/0 (5) Virulent
rLaSo
BCHN
>90 0.00 0.00 3/0 (10) Low
virulent
F & HN rLaSoVF
BCHN
49 1.69 2.20 4/3 (5) Virulent
P rBC/V-
Stop
63 1.54 1.07 0/0 (5) Virulent
rBC/Edit 80 1.19 0.79 1/0 (5) Virulent
a Mean death time in embryonating eggs (hours) (<60: velogen; 60–90:
mesogen; >90: lentogen; Alexander, 1998).
b Intracerebral pathogenicity index in day-old chicks (0.0–0.5: lentogen; 1.0–
1.5: mesogen; 1.5–2.0: velogen; Alexander, 1998).
c Intravenous pathogenicity index in 6-week-old chickens. (0.0: lentogen;
0.0–0.5: mesogen; 2.0–3.0: velogen; Alexander, 1998).
d Intracloacal inoculation pathogenicity test in 6-week-old chickens; numbers
of birds showing clinical signs/number dead (total number inoculated). The
signs observed in chickens following intracloacal inoculation were tremors and
paralysis typical of a neurotropic virus infection. Those with severe paralysis
were euthanized and recorded as dead. No overt hemorrhagic lesions were
observed.
e Fusion cleavage site amino acid sequence; avirulent= low virulent fusion
cleavage site sequence, 112G/E-K/R-Q-G/E-R-L117; virulent=virulent fusion
cleavage site sequence, 112R/K-R-Q-K/R-R-F117.
f ND: not done.
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Chickens infected with either rBC LaSoHN or rBCG4
exhibited no signs of clinical disease. In comparison to the
parent strain (rBC), rBC LaSoHN virus induced less severe
histologic lesions with slightly decreased viral distribution.
Moderate encephalitis (Fig. 2E) was detected in birds with
rBC LaSoHN at 10 dpi, but no viral nucleoprotein/mRNA
was present in the brain. No overt histologic lesions or
viral nucleoprotein/mRNA were present in tissues from
birds infected with rBCG4. Infections with rLaSo BCHN
produced no overt clinical signs of disease and no
significant histologic lesions. Viral distribution was
restricted to the inoculation site. In contrast, birds infected
with rLaSoVF BCHN had severe nervous signs such as
leg paralysis and head tremor (at and after 5 dpi) with
60% mortality. Principal histologic lesions were pancreatic
exocrine cell necrosis, encephalitis, and lymphoid depres-
sion predominantly in the thymus. Virus was distributed
systemically, including lymphoid tissues (Fig. 2F), gastro-
intestinal tract, pancreas, respiratory tissues, heart (Fig.
2G), and the brain as detected by either or both IHC or
ISH.Phosphoprotein gene mutations
Both viruses with mutated P gene (rBC/V-Stop and rBC/
Edit) displayed reduced virulence in chickens compared to
the parent virus (rBC). Although neither P gene mutation
clone caused any apparent clinical disease in chickens, rBC/
V-Stop had slightly more histologic lesions than did rBC/
Edit in the brain. Birds with rBC/V-Stop showed mild to
moderate encephalitis, whereas birds with rBC/Edit did not
have encephalitis. Viral distribution of both clones detect-
able with IHC or ISH was restricted to inoculation sites
(Fig. 2H).
Virus isolation from swabs and serology
Virus was isolated from both oral and cloacal swabs of birds
infected with wtBC, rBC, rLaSoVF, rBC LaSoHN, rBCG4,
rLaSoVF BCHN, and rBC/V-Stop and from only oral swabs of
birds infected with wtLaSo, rLaSo, and rLaSo BCHN. No virus
was isolated from either oral or cloacal swab of birds inoculated
with rBC/Edit or from any of the phosphate buffer saline (PBS)-
inoculated birds.
The hemagglutination–inhibition (HI) titers of pre-infection
and all PBS inoculated chickens were 2 or less. An HI titer of
greater than 8 was considered positive. All blood samples
collected at days 10 and 14 dpi of wtBC, rBC, rLaSo, rLaSoVF,
rBC LaSoHN, rLaSo BCHN, and rLaSoVF BCHN were HI
positive. Four of six birds sampled at 10 and 14 dpi from
wtLaSo, rBCG4, and rBC/V-Stop groups had seroconverted,
but only two of those sampled from the rBC/Edit group had
seroconverted, one at day 10 and one at day 14.
Nucleotide and predicted amino acid sequence analysis
Sequence analysis performed on isolates from oral swabs at
5 dpi confirmed that wtBC, rBC, rLaSoVF, rBC LaSoHN,
rBCG4, rLaSoVF BCHN, and rBC/V-Stop had the virulent F
cleavage motif 112RRQKRF117 whereas rLaSo had the amino
acid sequence 112GRQGRL117 typical of the low virulence F
cleavage activation site. The HN gene of rBC LaSoHN was
confirmed as the same as that of LaSota. It was confirmed that
the HN gene of rLaSo BCHN and rBCG4 was the same as that
of Beaudette C, and rBCG4 contained the deletion at
glycosylation site 4.
Discussion
This study is the first to investigate the influence of NDV
gene mutations or substitutions involving the F, P, and HN
genes on the pathogenesis of disease in chickens inoculated via
a natural route of infection. The virulence and pathogenesis of
two NDV isolates, Beaudette C (virulent) and LaSota (low
virulent), along with their infectious clones were compared to
determine associations among the virus strain's pathogenicity
indices along with their ability to disseminate and cause disease
in chickens.
Each wild-type virus (wtBC and wtLaSo) and its infectious
clone (rBC and rLaSo, respectively) had very similar
Table 2
Clinical–pathologic results (morbidity, mortality, and viral distribution) for chickens inoculated with wild-type NDV strains and their infectious clones,
14-day-observation
wtBC rBC wtLaSo rLaSo rLaSoVF rBC LaSoHN rBCG4 rLaSo BCHN rLaSoVF BCHN rBC/V-Stop rBC/Edit
No. sick/dead (of 10) a 10/6 10/3 0/0 0/0 8/6 0/0 0/0 0/0 6/6 0/0 0/0
No. positive (of 21) b 21 10 0 2 10 7 0 1 12 3 2
Spleen 5 c 5 10 5
Thymus 6 5 10 5
Bursa 5 5 10 5
H. gland d 6 4 5 2 5
Pancreas 6 8 8
Proven e 6
Intestine 6 8
Air sac 5 5 5
Trachea 5 5
Lung 5 5 5
Heart 5 5 5
Esophagus 2
Pharynx 2 5 14 5 2 5
Crop 2 8 10




Marrow f 5 10
Eyelid 5 10 5 2 5 5 2
Turbinate 2 10 2 5 14 5
a Numbers of birds with clinical signs/number with severe disease, typically severe paralysis, which were euthanized and recorded as dead. Total number of birds is
10.
b Numbers of IHC- and/or ISH-positive tissues. Total number is 21.
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clinicopathologic assessment study, birds infected with rBC
had lower mortality with less extensive viral distribution, in
comparison to wtBC. Sequence analysis of viruses isolated from
swabs confirmed that rBC and wtBC had identical amino acid
sequences at the fusion cleavage site. However, nucleotide and
amino acid differences between the rBC and the wtBC were
reported previously (Krishnamurthy et al., 2000). These
included a total of five nucleotide changes: T5464C, A7915G,
C10167T, A10877C, and C12239T. Three of these nucleotide
(nt) differences resulted in amino acid (aa) changes: nt 7915 in
the HN gene, resulting in change of amino acid threonine to
alanine (aa position 502); nt 10167 in the L gene, resulting in
change of amino acid threonine to methionine (aa position 596);
and nt 10877 in the L gene, resulting in change of amino acid
methionine to leucine (aa position 833). Although rBC
demonstrated decreased virulence in clinicopathologic assess-
ment with 4-week-old chickens, it still induced systemic
infection and had virulent pathogenicity indices. These differ-
ences between wtBC and rBC could be due to the previously
reported changes in the HN and L genes.
In contrast, both wtLaSo and rLaSo were very similar to each
other as both had low pathogenicity indices did not cause any
overt disease in 4-week-old chickens, and viral distribution was
restricted to the inoculation site.Fusion gene
The pathogenicity indices of rLaSoVF and rLaSoVF
BCHN were higher than those of rLaSo and rLaSo BCHN
and similar to those of rBC. Chickens infected with rLaSoVF
or rLaSoVF BCHN showed severe clinical signs of disease
and tissue damage with systemic viral distributions similar to
the disease seen from an rBC infection. In contrast, only mild
disease was evident in birds infected with rLaSo or rLaSo
BCHN. Therefore, it is evident that modifying the F cleavage
site of a low virulent virus to the virulent motif resulted in an
increase of the pathogenicity indices (Fig. 3A) and severity of
clinicopathologic disease (Fig. 3B). These results indicate that
the amino acid sequence at the fusion cleavage site played a
major role in the virulence of these viruses as originally
described among wild-type viruses (Glickman et al., 1988;
Nagai et al., 1976).
Further evidence for the importance of the sequence of
the fusion cleavage site in virus dissemination is the
observation that chickens infected with wild-type or
recombinant viruses which had a virulent fusion cleavage
site, except for rBC/Edit, shed virus recoverable in both oral
and cloacal swabs. In contrast, those infected with viruses
that had the low virulence motif at that site shed virus
recoverable only from oral swabs.
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Chimeras created by rBC and rLaSo HN gene exchange
among the rBC, rLaSo, and rLaSoVF backbones had variableeffects. Both HN proteins are comprised of 577 amino acids
(GenBank accession nos. AAG30929 and AAC28376, res-
pectively). The substitution of the LaSota HN to create rBC
LaSoHN reduced the ICPI although the pathogenicity
Fig. 3. Effects of NDV LaSota F gene mutations on (A) ICPI scores (maximum
2.0) and (B) viral distribution in 4-week-old chickens (numbers of positive
tissues by IHC or ISH; total 21 tissues). (a) An up direction of the arrow
indicates a change that increased virulence. (b) Fusion protein cleavage site
converted to the consensus sequence of virulent NDV strain.
Fig. 4. Effects of NDV HN gene substitutions or mutations on (A) ICPI scores
(maximum 2.0) and (B) viral distribution in 4-week-old chickens (numbers of
positive tissues by IHC or ISH; total 21 tissues). (a) An up direction of the arrow
indicates a change that increased virulence, a down direction indicates a
decreased virulence, and an even arrow indicates no change in virulence. (b) HN
gene from lentogenic strain (rLaSo). (c) HN gene with glycosylation site 4
mutation. (d) HN gene from velogenic strain (rBC).
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markedly decreased compared to rBC in the pathogenesis
assessment. Chickens infected with rBC LaSoHN showed no
overt clinical signs of disease, and virus was distributed in
multiple tissues but in fewer tissues than in those birds
infected with rBC (Fig. 4B). Interestingly, in birds infected
with rBC LaSoHN, mild encephalitis was observed histolo-
gically, but no virus was detected in brain by either IHC or
ISH. The opposite chimera, substitution of virulent HN into a
low virulent virus to generate rLaSo BCHN, also caused
decreases in pathogenicity and disease severity, but only
slightly compared to the parent virus rLaSo (Figs. 4A and B).
In contrast, addition of the virulent HN to rLaSoVF to
generate rLaSoVF BCHN retained high pathogenicity and
increased the severity of disease (Figs. 3A, B and Figs. 4A,
B). These results suggest that both the virulent F cleavage
motif and the HN of a virulent virus are required within either
a low virulent or virulent backbone to maximize both
virulence and disease severity of these infectious clones.
The importance of the F and HN interaction has been reportedFig. 2. Histopathology, immunohistochemistry (IHC) for viral nucleoprotein, and in
infected with wild-type NDV strains and their infectious clones. Scale bar=30 μm.
detected in macrophages and lymphocytes. ISH, Mayer's hematoxylin counterstain. (
detected in cells within molecular layer. IHC, Mayer's hematoxylin counterstain. (C
detected in epithelial cells. IHC, Mayer's hematoxylin counterstain. (D) Pancreas; c
degenerative exocrine cells. IHC, Mayer's hematoxylin counterstain. (E) Cerebellu
encephalitis with Purkinje cells degeneration. Hematoxylin and eosin stain. (F) Bu
detected in macrophages and lymphocytes, mainly within interfollicular areas. ISH, M
with rLaSoVF BCHN. Viral antigen was detected in myocytes and infiltrating macro
infected 2 days previously with rBC/V-Stop. Viral antigen was detected in glandula
hematoxylin counterstain.previously, an interaction that is optimal when the F and HN
originate with the same virus (Gravel and Morrison, 2003;
Takimoto et al., 2002).
The loss of HN glycosylation site 4 within a virulent virus,
rBCG4, moderately decreased pathogenicity compared to the
parent virus, rBC (Fig. 4A). However, the virus induced no
overt clinicopathologic disease in 4-week-old chickens, and
viral nucleoprotein/mRNA was not detected in any tissues by
either IHC or ISH (Fig. 4B). Similar reduced pathogenicity had
been reported previously by Panda et al. (2004a) and an even
greater reduction in virulence of this virus was evident in the
natural route infections in the pathogenesis component of the
present study. The previously observed slow replication with
reduced neuraminidase activity and fusogenicity of the virus
(Panda et al., 2004a) may have greater influence on a natural
route infection than one initiated by systemic inoculation in the
pathogenicity tests.situ hybridization (ISH) for viral mRNA on tissues from 4-week-old chickens
(A) Spleen; chicken infected 9 days previously with wtBC. Viral mRNA was
B) Cerebellum; chicken infected 14 days previously with rBC. Viral antigen was
) Air sac; chicken infected 5 days previously with rLaSoVF. Viral antigen was
hicken infected 5 days previously with rLaSoVF. Viral antigen was detected in
m; chicken infected 10 days previously with rBC LaSoHN. Non-suppurative
rsa; chicken infected 5 days previously with rBC LaSoHN. Viral mRNA was
ayer's hematoxylin counterstain. (G) Heart; chicken infected 5 days previously
phages. IHC, Mayer's hematoxylin counterstain. (H) Harderian gland; chicken
r epithelial cells and infiltrating macrophages and lymphocytes. IHC, Mayer's
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The pathogenicity indices of both clones with P gene
mutations, rBC/V-Stop and rBC/Edit, were lower than those
of rBC as parent virus (Fig. 5A) but much higher than those
of rLaSo. However, the disease severity and viral distribution
in tissues of both clones were markedly decreased compared
to those of the parent virus (rBC) (Fig. 5B) and were similar
to those of rLaSo. The pathogenesis results were due in part to
the observation that rBC/Edit clone was found to be poorly
infectious for chickens inoculated by the natural route. These
results suggest that not only the V protein but also the
possible W protein have a role in virus virulence and an even
greater role in virus pathogenesis. The results from the natural
route infections may be consistent with the role of the V
protein as an interferon antagonist (Huang et al., 2003; Park et
al., 2003b).
Our findings are summarized as follows: (i) the presence
of a virulent F cleavage activation site within a low
virulent backbone increased pathogenicity indices as well
as severity of clinicopathologic disease and viral distribu-
tion in chickens; (ii) the presence of a low virulent HN
within a virulent backbone mildly decreased viral patho-
genicity and resulted in no clinical disease; (iii) the
presence of a virulent HN within a low virulent backbone
did not change either pathogenicity indices or severity of
clinicopathologic disease in chickens; (iv) the loss of
glycosylation site 4 from the HN within a virulent virus
moderately decreased viral pathogenicity and resulted in no
clinicopathologic disease; and (v) the modifying the P gene
within a virulent virus caused mildly decreased viral
pathogenicity indices and the viruses caused no clinical
disease with markedly decreased viral distribution.Fig. 5. Effects of NDV P gene mutations on (A) ICPI scores (maximum 2.0) and
(B) viral distribution in 4-week-old chickens (numbers of positive tissues by
IHC or ISH; total 21 tissues). (a) A down direction of the arrow indicates a
change that decreased virulence. (b) Lack expression of V protein. (c) Lack
expression of V and W proteins.The data provide further evidence consistent with the
hypothesis that the pathogenicity of NDV is multigenic
(de Leeuw et al., 2005; Huang et al., 2004) and at least the F,
HN, and P genes influence viral pathogenicity as well as
clinicopathological disease in chickens. Although several of the
infectious clones attained virulence similar to wtBC, none of
them resulted in the extensive virus distribution in tissues
similar to that parent virus.
Materials and methods
Viruses
Two reference strains of NDV, a virulent strain Beaudette C
and a low virulent strain LaSota, their recombinants, and
recombinants with mutations or chimeras were utilized in this
study. Recombinant viruses of Beaudette C (rBC) and LaSota
(rLaSo) were constructed as described previously by Krishna-
murthy et al. (2000) and by Huang et al. (2001), respectively.
Recombinant LaSota virulent F (rLaSoVF) had genetically
modified fusion cleavage site from 112GRQGRL117 to
112RRQKRF117, a typical virulent motif, the same as that of
Beaudette C. Hemagglutinin–neuraminidase (HN) gene chi-
meras, rBC with HN gene from rLaSota (rBC LaSoHN) and
rLaSota with HN gene from rBC (rLaSo BCHN), were
constructed as previously described by Huang et al. (2004).
In addition, the fusion cleavage site of rLaSo BCHN was
modified from avirulent to virulent motif 112RRQKRF117
(rLaSoVF BCHN). Recombinant BC with a mutation of the N-
linked glycosylation site 4, at residue 481 (rBCG4), resulting in
elimination of the site for glycosylation, was constructed as
previously described by Panda et al. (2004a). Two infectious
clones with P gene mutations that lacked expression of the V
protein (rBC/V-Stop) or both the V and possible W proteins
(rBC/Edit) were constructed as described previously by Huang
et al. (2003). For comparison to the infectious clones, wild
types of Beaudette C (wtBC) and LaSota (wtLaSo) were also
utilized. Viruses were propagated in embryonating eggs at the
Southeast Poultry Research Laboratory (SEPRL), and the
amnioallantoic fluid harvested from those infected eggs was
used as inoculum after proper dilution.
Eggs and chickens
The source of embryonating chicken eggs and chickens was
the SEPRL SPF White Leghorn flock (King, 1993). Birds were
housed in negative-pressure isolators under BSL-3 agriculture
conditions at SEPRL and provided feed and water ad libitum.
Embryonating eggs were used for viral propagation, isolation,
titration, and the MDT test. Chickens were utilized for the ICPI,
IVPI, and intracloacal inoculation tests as well as in the
clinicopathologic assessment experiment.
Pathogenicity index tests
To characterize the virus, four standard pathogenicity assays
were performed (Alexander, 1998). These included the MDT in
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inoculated for the ICPI at one-day of age and the IVPI and
intracloacal inoculation at 6 weeks of age (Alexander, 1998).
Clinicopathologic assessment in chickens
Each of eleven groups of ten 4-week-old chickens was
inoculated via instillation bilaterally in the conjunctival sac with
a total of 0.1 ml of one of the viruses or PBS as a non-infected
control: wild-type viruses (wtBC and wtLaSo), their clones
(rBC and rLaSo), rLaSo with a virulent F motif (rLaSoVF),
their HN chimeras (rLaSo BCHN and rBC LaSoHN), rLaSo
BCHN with virulent F motif (rLaSoVF BCHN), rBC with G4
deletion of HN (rBCG4), or rBC with P gene modifications
(rBC/V-Stop and rBC/Edit). Each bird received approximately
105.0 50% embryo infectious doses (EID50) of viral inoculum
based on a titration in embryonated eggs to confirm the
administered dose.
The birds were monitored clinically every day, and two birds
of each group were euthanized after collecting oral and cloacal
swabs at 2, 5, 10, and 14 dpi. Earlier sampling than scheduled
occurred in birds that were euthanized when they exhibited
severe clinical signs. Tissues (eyelid, spleen, thymus, bursa,
Harderian gland, proventriculus, small intestine, cecal tonsils,
large intestine, air sac, trachea, lung, heart, esophagus, pharynx,
crop, brain, liver, pancreas, kidney, comb, head of left femur
including bone marrow, and turbinate) were collected and fixed
by immersion in 10% neutral buffered formalin for approxi-
mately 52 h. Blood samples for serology were also collected at
10 and 14 dpi. The sections of femur and turbinates were
decalcified in 5% formic acid for 3–4 h. All sampled tissues
were routinely processed into paraffin, and 3-μm sections were
sectioned for hematoxylin and eosin staining, immunohisto-
chemistry, and in situ hybridization.
Immunohistochemistry (IHC)
All sampled tissues were examined by IHC to detect viral
nucleoprotein. Briefly, the protocol was as follows. After
deparaffinization, tissue sections were subjected to antigen
retrieval by microwaving for 10 min at full power in Vector
antigen unmasking solution (Vector Laboratories, Burlingame,
CA) followed by blocking with universal blocking reagent
(Biogenex, San Ramon, CA) as recommended by the
manufacturer. The primary antibody, made in rabbits, was
anti-peptide (nucleoprotein), used at a 1:8000 dilution (Kom-
mers et al., 2001). Detection system was an avidin–biotin–
alkaline phosphatase (Vector Laboratories) with a Vector Red
substrate (Vector Laboratories). Sections were counterstained
lightly with hematoxylin and coverslipped for a permanent
record.
In situ hybridization (ISH)
All sections of eyelid, spleen, thymus, bursa, and Hard-
erian gland, as well as other selected tissue sections, were
probed with a negative sense digoxigenin-labeled 850-baseriboprobe representing the 5′ end of the matrix gene of B1 as
described previously (Brown et al., 1999; Kommers et al.,
2001, 2002, 2003). Briefly, tissues sections were deparaffi-
nized, rehydrated, and digested with 30 μg/ml proteinase K
for 15 min at 37 °C. Hybridization was conducted overnight
at 42 °C with approximately 20 ng of probe in the
prehybridization solution. After stringent washes, anti-digox-
igenin alkaline phosphate was added to the sections. The
development was with chromogen/substrate nitroblue tetra-
zolium (NBT)/5-bromo, 4-chloro, 3-indolylphosphate (BCIP).
Tissues were counterstained lightly with hematoxylin and
coverslipped with Permount.
Virus isolation from swabs
For those chickens used in the clinicopathologic assessment
experiment, immediately prior to euthanasia, oral and cloacal
swabs were obtained from each bird. Swabs were collected at 2,
5, 10, and 14 dpi, except birds inoculated with wtBC (2, 5, 6, 9,
and 10 dpi), with rLaSoVF (2, 4, 5, 8, 9, 10, and 14 dpi), and
with rLaSoVF BCHN (2, 4, 5, 8, 10, and 14 dpi). Each swab
was placed in a tube containing 1.5 ml of brain-heat infusion
broth (BHI) with antibiotics (2000 U/ml penicillin G, 200 μg/ml
gentamicin sulfate, and 4 μg/ml amphotericin B; Sigma
Chemical Co., St. Louis, MO) (Alexander, 1998; King, 1993).
The swab tubes were centrifuged at 1000×g for 20 min and
supernatant fluids were removed for inoculation of 9- to 10-day-
old SPF embryonating chicken eggs. Newcastle disease virus-
infected dead or surviving embryos were identified by
hemagglutination (HA) activity in amnioallantoic fluid har-
vested from chilled eggs. Newcastle disease virus was
confirmed in HA-positive samples by a hemagglutination–
inhibition (HI) test with NDV-specific antiserum (Alexander,
1998).
Serology
The HA and HI assays were conducted by conventional
microtiter methods (King, 1993) with serum separated from the
blood samples taken at 10 and 14 dpi. An exception to that
sampling schedule involved birds inoculated with wtBC which
were collected at 9 and 10 dpi due to the early severe disease
onset and subsequent euthanasia. Four HA units of beta
propiolactone (BPL) inactivated NDV LaSota was used as
test antigen in completing the HI tests.
Nucleotide and predicted amino acid sequence analysis
Newcastle disease virus was isolated from oral swabs taken
at 5 dpi. The isolates were replicated in embryonating eggs, and
RNA was extracted directly from amnioallantoic fluid.
Oligonucleotide reverse transcription polymerase chain reaction
(RT-PCR) primers were designed to amplify regions of the
fusion protein gene, including the fusion protein cleavage site
and the matrix protein gene region encoding the nuclear
localization signal of the matrix protein (Seal et al., 1995).
Primers amplifying the HN gene were also utilized (Panda et al.,
342 N. Wakamatsu et al. / Virology 353 (2006) 333–3432004a; Sakaguchi et al., 1989). A single tube RT-PCR for
genomic NDV RNA was completed with Superscript™ (Life
Technologies, Gaithersburg, MD) and Amplitaq™ (PE Biosys-
tems, Foster City, CA) polymerase. Amplification products
were separated by gel electrophoresis in 1.0% agarose with
Tris–borate buffer, and stained with ethidium bromide.
Amplification products were purified with Microcon™ (Ami-
con, Belford, MA) spin filters and spectrophotometrically
quantified. Additionally, amplification products were cloned
with the TA cloning system™ according to the methods
described by the manufacturer (Invitrogen, San Diego, CA).
Direct double-stranded nucleotide sequencing was completed
with Taq polymerase (Applied Biosystems, Inc., Foster City,
CA) with the oligonucleotide primers used for RT-PCR,
fluorescent-labeled dideoxynucleotides, and an automated
nucleic acid sequencer (Seal et al., 1995).
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